In a heartbreaking incident, 20 children in Madhya Pradesh have died after consuming a contaminated cough syrup, while five others remain under treatment for kidney failure, according to Deputy Chief Minister Rajendra Shukla. Of the victims, 17 were from Chhindwara, two from Betul, and one from Pandhurna. The children had reportedly taken Coldrif syrup after suffering from fever and cold, which soon led to vomiting and difficulty in urination.
Swift Government Response
Speaking after visiting the affected children in Nagpur hospitals, Mr. Shukla confirmed that two more deaths occurred on Tuesday and one on Monday night, raising the toll to 20. He assured that the state government will bear the full cost of treatment for the hospitalized children. “Chief Minister Mohan Yadav has instructed the formation of three special teams in Nagpur to support the families and ensure they face no financial or logistical burden,” a government statement said.
Toxic Compound Found in Syrup
The Coldrif syrup, manufactured by Sresan Pharmaceuticals in Kancheepuram, Tamil Nadu, was found to contain over 45% diethylene glycol (DEG)—a toxic chemical known to cause severe kidney damage and metabolic disorders. Following this revelation, Tamil Nadu and Madhya Pradesh banned the sale of the syrup. DEG is an industrial solvent used in antifreeze and brake fluids and is not approved for pharmaceutical use. Even small amounts can be deadly, especially for children.
Doctor Arrested Amid Public Outcry
Amid the investigation, the Madhya Pradesh Police arrested Dr. Praveen Soni, a government paediatrician from Parasia, Chhindwara, for prescribing the contaminated medicine to several of the deceased children. The manufacturer has also been booked, and a Special Investigation Team (SIT) has been formed to probe the case. However, Dr. Soni’s arrest sparked widespread protests by the Indian Medical Association (IMA) and local doctors, who claim he is being wrongly targeted.
Doctors Demand Release of Colleague
As reported by The Hindu, doctors in Parasia have launched an indefinite strike, demanding Dr. Soni’s immediate release. Dr. Ankur Batra, Secretary of the IMA Parasia unit, said, “Dr. Soni is a senior and respected paediatrician, not a criminal. The authorities should act against those responsible for manufacturing and approving the contaminated syrup, not the prescribing doctor.” Members of the dental and pharma associations have also joined the protest, with a silent rally planned for October 8.
Understanding the Contamination: What Went Wrong
As reported by NDTV, the recent tragedy highlights serious gaps in drug quality control and oversight in India’s pharmaceutical supply chain. According to regulatory findings, industrial-grade solvents such as diethylene glycol (DEG) or ethylene glycol (EG) may be mistakenly or fraudulently used in place of pharmaceutical-grade glycerine or propylene glycol. Because DEG and EG are colorless and odorless, they can easily mimic legitimate solvents unless rigorous testing methods—like gas chromatography—are used.
Past Incidents and Global Context
This is not an isolated event. In The Gambia (2022) and Uzbekistan (2023), DEG-contaminated Indian-made cough syrups were linked to the deaths of dozens of children. These recurring incidents underline the urgent need for stringent quality assurance, supplier verification, and global compliance with pharmaceutical standards.
Regulatory Actions in India
In response to the current crisis, the Union Health Ministry has taken several corrective measures:
- Banned and recalled all implicated Coldrif batches.
- Ordered statewide testing of cough syrups across districts.
- Issued an advisory against prescribing cough or cold syrups to children below two years.
- Formed expert panels to investigate regulatory lapses and recommend reforms.
Public Advisory: Safe Use of Cough Syrups
While the investigation continues, experts urge the public to practice informed caution:
- Use only doctor-prescribed medicines and avoid self-medication.
- Prefer single-agent syrups over combination drugs for children.
- Avoid using expired or unlabelled syrups.
- If symptoms persist, seek medical care instead of increasing dosage.
- Store medicines as per label instructions to maintain safety and efficacy.
A Wake-Up Call for Drug Safety
The Madhya Pradesh tragedy serves as a stark reminder of the urgent need to strengthen India’s pharmaceutical regulation and supply chain integrity. While authorities race to pinpoint accountability, public awareness and adherence to medical guidance remain crucial. Responsible prescribing, manufacturing vigilance, and stricter enforcement are key to ensuring that such preventable tragedies never happen again.